Delivery Order SPE2DR25D6028-SPE2DR26FASKH
Award Date 12/5/25
Potential Completion Date 1/5/26
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Naloxone 2 mg/2 mL syringes with a ceiling value of $1,721.78. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order is set for ultimate completion by November 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,053.07 and an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,595.87 to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials. The contract, awarded on November 10, 2025, carries a firm fixed price structure with an ultimate completion date of November 12, 2025. The award represents a competitive procurement with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,554.28. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Naloxone HCL 4 mg nasal spray in two-spray units, with a contract ceiling value of $6,605.18. This is a firm fixed-price delivery order executed without set-aside provisions, indicating competitive award to a qualified vendor. The performance location is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and the delivery deadline is set for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes, with a contract value of $1,647.88 and an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract reflects the firm fixed-price delivery order structure typical of the DLA's pharmaceutical procurement approach. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 4 mg/10 mL vials on July 11, 2025, with a contract ceiling value of $10,276.45. This firm fixed price delivery order, with an ultimate completion date of July 14, 2025, represents a competitively awarded non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Naloxone 0.4 mg/mL vials valued at $4,056.58 with an ultimate completion date of December 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under open competition. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $3,834.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-dose units) on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Naloxone 4 mg/10 mL vials with a ceiling value of $11,898.39 and a firm fixed price structure. This is a competitively awarded, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...